Related Articles
Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer
Low-dose docetaxel, estramustine and prednisolone combination chemotherapy for castration-resistant prostate cancer
Effect of dutasteride on castration‑resistant prostate cancer
Baseline neutrophil‑to‑lymphocyte ratio predicts the prognosis of castration‑resistant prostate cancer treated with abiraterone acetate
Identification of favorable subgroups for alternative anti‑androgen therapy in castration‑resistant prostate cancer